Delving into the Latest Updates on Shenzhen Immuno Cure Biomedical Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Immune System Diseases

Urogenital Diseases

DNA vaccine

Therapeutic vaccine

Autologous CAR-T

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	2
Infectious Diseases	2
Immune System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

DNA vaccine	2
Therapeutic vaccine	2
Autologous CAR-T	1
Monoclonal antibody	1

Top 5 Target	Count

PD-1(Programmed cell death protein 1)	3

主要目的：研究治疗用艾滋病核酸注射液（ICVAX）免疫保护机制。次要目的：评估治疗用艾滋病核酸注射液（ICVAX）抑制HIV-1 RNA病毒载量的有效性；评估ICVAX联合ART治疗在分析性治疗中断（Analytical treatment interruption，ATI）研究中的安全性。探索性目的：深入探索ICVAX 免疫保护机制和病毒学相关机制。

[Translation]

Primary Objective: To investigate the immunoprotective mechanism of therapeutic HIV nucleic acid injection (ICVAX). Secondary Objectives: To evaluate the efficacy of therapeutic HIV nucleic acid injection (ICVAX) in suppressing HIV-1 RNA viral load; to evaluate the safety of ICVAX in combination with ART in an analytical treatment interruption (ATI) study. Exploratory Objectives: To further explore the immunoprotective mechanism and virological mechanisms of ICVAX.

Start Date-

Sponsor / Collaborator

Shenzhen Immuno Cure Biomedical Co., Ltd.

100 Clinical Results associated with Shenzhen Immuno Cure Biomedical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenzhen Immuno Cure Biomedical Co., Ltd.

Login to view more data

100 Deals associated with Shenzhen Immuno Cure Biomedical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenzhen Immuno Cure Biomedical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

2

1

Phase 1

Phase 2

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Therapeutic HIV DNA vaccine (Yicura BioMed)	HIV Infections More	Phase 2
ICCOV ( PD-1 )	COVID-19 More	Phase 1
IMC-004 ( PD-1 )	Neoplasms More	Preclinical
IMC-003 ( PD-1 )	Mesothelioma More	Preclinical